Insider Transactions in Q3 2022 at Eli Lilly & CO (LLY)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
101,631
-0.01%
|
$34,148,016
$336.99 P/Share
|
|
Sep 19
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+3.2%
|
$10,065
$305.09 P/Share
|
|
Sep 19
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+0.33%
|
$14,030
$305.09 P/Share
|
|
Sep 19
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+2.29%
|
$9,760
$305.09 P/Share
|
|
Sep 19
2022
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+18.33%
|
$10,065
$305.09 P/Share
|
|
Sep 19
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.05%
|
$10,065
$305.09 P/Share
|
|
Sep 19
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.07%
|
$11,285
$305.09 P/Share
|
|
Sep 01
2022
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-15.94%
|
$301,000
$301.0 P/Share
|
|
Aug 15
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
36
+0.07%
|
$11,268
$313.94 P/Share
|
|
Aug 15
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.05%
|
$10,016
$313.94 P/Share
|
|
Aug 15
2022
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+21.92%
|
$10,016
$313.94 P/Share
|
|
Aug 15
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+2.27%
|
$9,703
$313.94 P/Share
|
|
Aug 15
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
45
+0.32%
|
$14,085
$313.94 P/Share
|
|
Aug 15
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+3.22%
|
$10,016
$313.94 P/Share
|
|
Aug 12
2022
|
Jackson P Tai Director |
BUY
Open market or private purchase
|
Direct |
656
+1.03%
|
$199,424
$304.19 P/Share
|
|
Aug 10
2022
|
Alonzo Weems EVP, ERM & CECO |
SELL
Bona fide gift
|
Direct |
530
-6.51%
|
-
|
|
Aug 10
2022
|
Alonzo Weems EVP, ERM & CECO |
SELL
Open market or private sale
|
Direct |
656
-7.46%
|
$199,424
$304.5 P/Share
|
|
Jul 28
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
89,458
-0.04%
|
$29,789,514
$333.18 P/Share
|
|
Jul 26
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
1,601
-0.0%
|
$531,532
$332.52 P/Share
|
|
Jul 18
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
35
+0.07%
|
$11,235
$321.77 P/Share
|
|
Jul 18
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.04%
|
$9,951
$321.77 P/Share
|
|
Jul 18
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+3.22%
|
$9,951
$321.77 P/Share
|
|
Jul 18
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+2.25%
|
$9,630
$321.77 P/Share
|
|
Jul 18
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
44
+0.32%
|
$14,124
$321.77 P/Share
|
|
Jul 18
2022
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+27.43%
|
$9,951
$321.77 P/Share
|
|
Jul 15
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
17,310
-0.01%
|
$5,764,230
$334.0 P/Share
|
|
Jul 06
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
177,243
-0.04%
|
$58,490,190
$330.88 P/Share
|